DOMAIN THERAPEUTICS

Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression... Domain Therapeutics is creating value for its shareholders by bringing to the clinic its proprietary portfolio of programs in immuno-oncology and by creating early partnerships on other assets in other non immuno-oncology therapeutic area... Our mission: delivering game-changing immunotherapies Our vision: unveiling the immune potential of GPCR Our business model: corporate development and partnership Scroll back top

Also known as: Domain Therapeutics Canada, Domain Therapeutics France, Domain Therapeutics NA Inc., Domain Therapeutics SA

Primary location: Strasbourg - Illkirch France